Lensar (LNSR) EBT Margin Growth (3y) (2022 - 2026)
Lensar (LNSR) EBT Margin Growth (3y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | -305.00 |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -9.00 |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 55.00 |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 923.00 |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -480.00 |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 1,391.00 |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 2,114.00 |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -176.00 |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Lensar | 70.05 Mn | 72.73 Mn | 6.38 Mn | 11,528.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11,528.00 |
| Dec 31, 2025 | -14,051.00 |
| Sep 30, 2025 | -2,884.00 |
| Jun 30, 2025 | -136.00 |
| Mar 31, 2025 | -3,816.00 |
| Dec 31, 2024 | -4,917.00 |
| Sep 30, 2024 | 13,831.00 |
| Jun 30, 2024 | 8,346.00 |
| Mar 31, 2024 | -232,819.00 |
| Dec 31, 2023 | 9,625.00 |
| Sep 30, 2023 | 771.00 |
| Jun 30, 2023 | 5,907.00 |
| Mar 31, 2023 | -5,290.00 |
| Dec 31, 2022 | -2,381.00 |
| Sep 30, 2022 | -6,026.00 |